Aker Biomarine ASA
OSE:AKBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (14.6), the stock would be worth kr7.06 (93% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 207.6 | kr100.2 |
0%
|
| 3-Year Average | 14.6 | kr7.06 |
-93%
|
| 5-Year Average | 12.6 | kr6.06 |
-94%
|
| Industry Average | 12.6 | kr6.09 |
-94%
|
| Country Average | 8.4 | kr4.03 |
-96%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| NO |
A
|
Aker Biomarine ASA
OSE:AKBM
|
8.8B NOK | 207.6 | -40.1 | |
| JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
53.2T JPY | 324 863.9 | 540 752.8 | |
| CH |
|
Nestle SA
SIX:NESN
|
207B CHF | 13 | 23 | |
| US |
|
Mondelez International Inc
NASDAQ:MDLZ
|
73.6B USD | 16.6 | 30.6 | |
| FR |
|
Danone SA
PAR:BN
|
43.1B EUR | 11.4 | 23.8 | |
| ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
48.6B ZAR | 21.3 | 12.7 | |
| US |
|
Hershey Co
NYSE:HSY
|
37.8B USD | 16.7 | 43.2 | |
| CN |
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
232.8B CNY | 30 | 33.1 | |
| CN |
|
Muyuan Foods Co Ltd
SZSE:002714
|
230.9B CNY | 10.7 | 23.6 | |
| ZA |
A
|
Avi Ltd
JSE:AVI
|
33.1B ZAR | 10.8 | 12.8 | |
| CH |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
23.2B CHF | 44.3 | 31.7 |
Market Distribution
| Min | 0.8 |
| 30th Percentile | 5.1 |
| Median | 8.4 |
| 70th Percentile | 17.7 |
| Max | 7 081 |
Other Multiples
Aker Biomarine ASA
Glance View
Aker BioMarine AS operates as a biotech innovator and Antarctic krill-harvesting company which develops krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company is headquartered in Lysaker, Akershus. The company went IPO on 2020-07-06. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.
